These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3588514)

  • 1. Gastrointestinal transit rate-related absorption of emepronium: a study in mice.
    Hallén B; Sundwall A
    Pharmacol Toxicol; 1987 Mar; 60(3):199-205. PubMed ID: 3588514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ion pair formation and gastrointestinal absorption of emepronium.
    Hallén B; Sundwall A; Sandquist S
    Acta Pharmacol Toxicol (Copenh); 1985 Oct; 57(4):271-8. PubMed ID: 4083035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species differences in the intestinal excretion of emepronium.
    Hallén B; Räf L
    Pharmacol Toxicol; 1987 Oct; 61(4):242-5. PubMed ID: 3432202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal, biliary and intestinal clearance of a quaternary ammonium compound, emepronium in the dog.
    Hallén B; Sundwall A; Elwin CE; Vessman J
    Acta Pharmacol Toxicol (Copenh); 1979 Jan; 44(1):43-59. PubMed ID: 760387
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of emepronium bromide (Cetiprin) after intravenous administration in man.
    Pilbrant A; Norlén LJ
    Acta Pharmacol Toxicol (Copenh); 1985 Apr; 56(4):289-97. PubMed ID: 4024956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between gastric emptying and serum concentrations of emepronium in dogs and human volunteers.
    Hallén B; Massey A; Guilbaud O; Sundwall A
    Arzneimittelforschung; 1988 Oct; 38(10):1482-5. PubMed ID: 3196390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lack of effect of intramuscular emepronium bromide for urinary incontinence.
    Perera GL; Ritch AE; Hall MR
    Br J Urol; 1982 Jun; 54(3):259-60. PubMed ID: 7049303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A second look at emepronium bromide in urinary incontinence.
    Ritch AE; George CF; Castleden CM; Hall MR
    Lancet; 1977 Mar; 1(8010):504-6. PubMed ID: 65608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emepronium carrageenate: clinical effects and urinary excretion in treatment of female urge incontinence.
    Bagger PV; Fischer-Rasmussen W; Hansen R
    Scand J Urol Nephrol; 1985; 19(1):31-35. PubMed ID: 3895410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electron-capture GC determination of subnanogram amounts of emepronium bromide in serum.
    Hartvig P; Näslund B; Vessman J
    J Pharm Sci; 1976 Nov; 65(11):1707-9. PubMed ID: 994011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary incontinence in old age. A controlled clinical trial of emepronium bromide.
    Walter S; Hansen J; Hansen L; Maegaard E; Meyhoff HH; Nordling J
    Br J Urol; 1982 Jun; 54(3):249-51. PubMed ID: 7049301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological fate of C14-labelled ethyl (3,3-diphenyl-l-methyl-propyl) dimethylammoniumbromide Cetiprin, a monoquaternary ammonium compound.
    HANSSON E; SCHMITERLOW CG
    Acta Pharmacol Toxicol (Copenh); 1961; 18():183-90. PubMed ID: 13904475
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuromuscular paralysis caused by an overdose of emepronium bromide (Cetiprin).
    Ferguson A; Baker DA
    Arch Emerg Med; 1985 Jun; 2(2):79-80. PubMed ID: 4015801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emepronium bromide (Cetiprin) as a postoperative spasmolytic agent in transvesical prostatectomy.
    Syversen JH; Mollestad E; Semb LS
    Scand J Urol Nephrol; 1976; 10(3):201-3. PubMed ID: 795015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of parenteral emepronium bromide (Cetiprin) on postoperative vesical tenesms after transurethral resection of the prostate. A randomized, placebo-controlled study.
    Jørgensen L; Willumsen H; Lautorp JR; Paaschburg B; Kromann B; Andersen JT
    Int Urol Nephrol; 1987; 19(1):87-90. PubMed ID: 3294714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose titration in clinical trials. An example using emepronium carrageenate in detrusor instability.
    Massey JA; Abrams P
    Br J Urol; 1986 Apr; 58(2):125-8. PubMed ID: 3516295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute oesophagitis due to emepronium bromide.
    Hillman LC; Scobie BA; Pomare EW; Austad WI
    N Z Med J; 1981 Jul; 93(687):4-6. PubMed ID: 6943463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Emepronium (Cetiprin). An urinary bladder specific parasympatholytic].
    Hebjørn S
    Ugeskr Laeger; 1980 Feb; 142(8):536-7. PubMed ID: 7368412
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of emepronium bromide (Cetiprin) on symptoms and urinary bladder function after transurethral resection of the prostate. A double-blind randomized trial.
    Bonnesen T; Tikjøb G; Kamper AL; Nielsen AM; Andersen JT; Jørgensen SJ
    Urol Int; 1984; 39(5):318-20. PubMed ID: 6506368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.